Charles river laboratories launches off-the-shelf lentiviral vector packaging plasmids

Wilmington, mass.--(business wire)--charles river laboratories international, inc. (nyse: crl) today announced the launch of its off-the-shelf lentiviral vector (lvv) packaging plasmids, providing a streamlined solution to the challenges associated with plasmid sourcing in cell and gene therapies. cell and gene therapies often rely on plasmid dna (pdna) as a critical starting material. however, production challenges such as capacity bottlenecks and timeline pressures, as well as a need for proc.
CRL Ratings Summary
CRL Quant Ranking